Bcl-2 Antibody (Immunohistochemistry)

Bcl-2 Antibody (Immunohistochemistry)

The Bcl-2 Antibody is a key immunohistochemical reagent for detecting B-cell lymphoma 2 (Bcl-2) protein, a crucial regulator of apoptosis.
Bcl-2 inhibits programmed cell death, promoting cell survival and contributing to the pathogenesis of various tumors such as follicular lymphoma, DLBCL, breast, lung, colon, and prostate carcinomas.

Positive IHC staining for Bcl-2 shows brown cytoplasmic staining, making it an essential marker for differentiating benign from malignant lymphoid proliferations and for studying anti-apoptotic mechanisms in tumor biology.

🔬 Features and Benefits Bcl-2 Antibody

• Specific marker for anti-apoptotic pathways

• Distinct brown cytoplasmic staining pattern

• Applicable in lymphoma, breast, lung, and prostate cancer diagnosis

• Compatible with FFPE tissue and DAB chromogen systems

• Excellent stability: 18-month shelf life at 2–8 °C

💡 Diagnostic Applications

• Detection of Follicular Lymphoma and DLBCL

• Evaluation of Bcl-2 expression in solid tumors

• Research on cell survival and apoptosis regulation

• Differentiation of benign vs. malignant lymphoid neoplasms

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the exclusive representative of Talent Biomedical in Iran, supplies high-quality immunohistochemistry antibodies, including Bcl-2.
With a commitment to scientific precision, diagnostic reliability, and international standards, Fardad Azma Rad supports pathology laboratories and molecular diagnostic centers throughout Iran.

“Download Brochure”